57
survey and recommendations. [Electronic resource]. Haemophilia
2009; 15(3):639-58. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19444969?dopt=Abstract (20.10.2014)
33.
Hewson I, Makhmalbaf P, Street A, et al. Dental surgery with minimal
factor support in the inherited bleeding disorder population at the
Alfred Hospital. [Electronic resource]. Haemophilia 2011; 17(1):e185-
8. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20557354?dopt=Abstract (20.10.2014)
34.
Hvas AM, Sorensen HT, Norengaard L, et al. Tranexamic acid
combined with recombinant factor VIII increases clot resistance to
accelerated fibrinolysis in severe hemophilia A. [Electronic resource]. J
Thromb Haemost 2007; 5(12):2408-14. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18034766?dopt=Abstract (20.10.2014)
35.
Kasper CK. Products for clotting factor replacement in developing
countries. [Electronic resource]. Semin Thromb Hemost 2005 Nov;
31(5):507-12. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16276458?dopt=Abstract (20.10.2014)
36.
Kavakli K, Aydogdu S, Taner M, et al. Radioisotope synovectomy with
rhenium186 in haemophilic synovitis for elbows, ankles and shoulders.
[Electronic resource]. Haemophilia 2008; 14(3):518-23. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18371165?dopt=Abstract (20.10.2014)
37.
Kempton CL, Soucie JM, et al. In non-severe hemophilia A the risk of
inhibitor after intensive factor treatment is greater in older patients: a
case-control study. [Electronic resource]. JTH 2010 Oct; 8(10):2224-
31. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18371165?dopt=Abstract (20.10.2014)
38.
Khair K, Baker K, Mathias M, et al. Intranasal desmopressin (Octim): a
safe and efficacious treatment option for children with bleeding
disorders. [Electronic resource]. Haemophilia 2007;13(5):548-51.-
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17880442?dopt=Abstract (20.10.2014)
39.
Kouides PA, Byams VR, Philipp CS, et al. Multisite management study
of menorrhagia with abnormal laboratory haemostasis: a prospective
crossover study of intranasal desmopressin and oral tranexamic acid.
[Electronic resource]. Br J Haematol 2009; 145(2):212-20. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19236375?dopt=Abstract (20.10.2014)
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
58
40.
Kouides PA, Fogarty PF. How do we treat upper gastrointestinal
bleeding in adults with haemophilia? [Electronic resource].
Haemophilia 2010; 16(2):360-2. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19878336?dopt=Abstract (20.10.2014)
41.
Kulkarni R, Lusher J. Perinatal management of newborns with
haemophilia. [Electronic resource]. Br J Haematol 2001 Feb;
112(2):264-74.- Available at:
http://www.ncbi.nlm.nih.gov/pubmed/11167818?dopt=Abstract (20.10.2014)
42.
Leissinger C, Becton D, Cornell C Jr, Cox Gill J. High-dose DDAVP
intranasal spray (Stimate) for the prevention and treatment of bleeding
in patients with mild haemophilia A, mild or moderate type 1 von
Willebrand disease and symptomatic carriers of haemophilia A.
[Electronic resource]. Haemophilia 2001; 7(3):258-66. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/11380629?dopt=Abstract (20.10.2014)
43.
Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when
the cup runneth over. [Electronic resource]. Semin Thromb Hemost
2008; 34(8):747-61. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19214913?dopt=Abstract (20.10.2014)
44.
4Llinás A. The role of synovectomy in the management of a target
joint. [Electronic resource]. Haemophilia 2008; 14 (Suppl 3):177-82.
Yoon KH, Bae DK, Kim HS, Song SJ. Arthroscopic synovectomy in
haemophilic arthropathy of the knee. Int Orthop 2005; 29(5):296-300. -
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18510539?dopt=Abstract (20.10.2014)
45.
Luchtman-Jones L, Valentino LA, Manno C; Recombinant Therapy
Workshop Participants. Considerations in the evaluation of
haemophilia patients for short-term prophylactic therapy: a paediatric
and adult case study. [Electronic resource]. Haemophilia 2006;
12(1):82-6. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16409180?dopt=Abstract (20.10.2014)
46.
Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus
episodic treatment to prevent joint disease in boys with severe
hemophilia. [Electronic resource]. NEJM 2007; 357(6):535-44. -
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17687129?dopt=Abstract (20.10.2014)
47.
Mannucci PM, Bettega D, Cattaneo M. Patterns of development of
tachyphylaxis in patients with haemophilia and von Willebrand disease
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
59
after repeated doses of desmopressin (DDAVP). [Electronic resource].
Br J Haematol 1992; 82(1):87-93. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/1419807?dopt=Abstract (20.10.2014)
48.
Mannucci PM. Hemostatic drugs. [Electronic resource]. N Engl J Med
1998 Jul 23; 339(4):245-53. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/9673304?dopt=Abstract (20.10.2014)
49.
Mannucci PM, Gringeri A, Savidge G, et al; European- Australian
Haemophilia Collaborative Study Group. Randomized double-blind,
placebo-controlled trial of twice-daily zidovudine in asymptomatic
hemophiliacs. [Electronic resource]. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/7912097?dopt=Abstract (20.10.2014)
50.
Mannucci PM. Use of desmopressin (DDAVP) during early pregnancy
in factor VIII-deficient women. Blood 2005; 105(8):3382. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/15802549 (20.10.2014)
51.
Martinowitz U, Luboshitz J, Bashari D, et al. Stability, efficacy, and
safety of continuously infused sucrose-formulated recombinant factor
VIII (rFVIII-FS) during surgery in patients with severe haemophilia.
[Electronic resource]. Haemophilia 2009; 15(3):676-85. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19298381?dopt=Abstract (20.10.2014)
52.
Meijer P, Verbruggen B. The between-laboratory variation of factor
VIII inhibitor testing: the experience of the external quality assessment
program of the ECAT foundation. [Electronic resource]. Semin Thromb
Hemost 2009; 35(8):786-93. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20169515?dopt=Abstract (20.10.2014)
53.
Mortazavi SM, Heidari P. Retrograde intramedullary nailing of
supracondylar femoral fractures in haemophilic patients. [Electronic
resource]. Haemophilia 2008; 14(3):661-664. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18397284?dopt=Abstract (20.10.2014)
54.
Neunert CE, Miller KL, Journeycake JM, et al. Implantable central
venous access device procedures in haemophilia patients without an
inhibitor: systematic review of the literature and institutional
experience. [Electronic resource]. Haemophilia 2008; 14(2):260-70. -
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18179577?dopt=Abstract (20.10.2014)
55.
Operskalski EA, Kovacs A. HIV/HCV co-infection: pathogenesis,
clinical complications, treatment, and new therapeutic technologies.
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
60
[Electronic resource]. Curr HIV/AIDS Rep 2011 Mar; 8(1):12-22. -
Available at:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035774/ (20.10.2014)
56.
Petrini P, Seuser A. Haemophilia care in adolescents – compliance and
lifestyle issues. [Electronic resource]. Haemophilia 2009; 15 Suppl
1:15-9.- Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19125936?dopt=Abstract (20.10.2014)
57.
Quon DV, Konkle BA. How we treat haematuria in adults with
haemophilia. [Electronic resource]. Haemophilia 2010; 16(4):683-5. -
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20041958?dopt=Abstract (20.10.2014)
58.
Ragni MV, Journeycake JM, Brambilla DJ. Tissue plasminogen
activator to prevent central venous access device infections: a
systematic review of central venous access catheter thrombosis,
infection and thromboprophylaxis. [Electronic resource]. Haemophilia
2008; 14(1):30-8.- Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18005145?dopt=Abstract (20.10.2014)
59.
Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of
haemophilic synovitis, target joints, and pain in adults and children
with haemophilia. [Electronic resource]. Haemophilia 2006; 12(5):514-
7. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16919082?dopt=Abstract (20.10.2014)
60.
Recht M, Pollmann H, Tagliaferri A, et al. A retrospective study to
describe the incidence of moderate to severe allergic reactions to factor
IX in subjects with haemophilia B. [Electronic resource]. Haemophilia
2011; 17(3):494-9. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21518148?dopt=Abstract (20.10.2014)
61.
Rodriguez-Merchan EC. Aspects of current management: orthopaedic
surgery in haemophilia. [Electronic resource]. Haemophilia 2012;
18(1):8-16. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21535324?dopt=Abstract (20.10.2014)
62.
Rodriguez-Merchan EC. Bone fractures in the haemophilia patient.
[Electronic resource]. Haemophilia 2002; 8(2):104-11. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/11952845?dopt=Abstract (20.10.2014)
63.
Ruiz-Sáez A, Hong A, Arguello A, Echenagucia M, Boadas A,
Fabbrizzi F, Minichilli F, Bosch NB. Pharmacokinetics,
thrombogenicity and safety of a double viral inactivated factor IX
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
61
concentrate compared with a prothrombin complex concentrate.
[Electronic resource]. Haemophilia 2005; 11(6):583-8. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16236107?dopt=Abstract (20.10.2014)
64.
Santagostino E, Colombo M, Rivi M, et al. A 6-month versus a 12-
month surveillance for hepatocellular carcinoma in 559 hemophiliacs
infected with the hepatitis C virus. [Electronic resource]. Blood 2003;
102(1):78-82. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/12649165 (20.10.2014)
65.
Schild FJ, Mauser-Bunschoten EP, Verbout AJ, Van Rinsum AC,
Roosendaal G. Total knee arthroplasty in hemophilic arthropathy:
efficiency of clotting factor usage in multijoint procedures. [Electronic
resource]. J Thromb Haemost 2009; 7(10):1741-3. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19682237?dopt=Abstract (20.10.2014)
66.
Seuser A, Boehm P, Kurme A, Schumpe G, Kurnik K. Orthopaedic
issues in sports for persons with haemophilia. [Electronic resource].
Haemophilia 2007; 13(Suppl 2):47-52. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17685925?dopt=Abstract (20.10.2014)
67.
Seuser A, Berdel P, Oldenburg J. Rehabilitation of synovitis in patients
with haemophilia. [Electronic resource]. Haemophilia 2007; 13 Suppl
3:26-31. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/17822518?dopt=Abstract (20.10.2014)
68.
Sica DA, Gehr TWG. Desmopressin: safety considerations in patients
with chronic renal disease. [Electronic resource]. Drug Safety 2006;
29:553–556. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/16808548?dopt=Abstract (20.10.2014)
69.
Singleton T, Kruse-Jarres R, Leissinger C. Emergency department care
for patients with hemophilia and von Willebrand disease. [Electronic
resource]. J Emerg Med 2010 Aug; 39(2):158-65. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18757163?dopt=Abstract (20.10.2014)
70.
Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for
abnormalities of coagulation tests and clinical coagulopathy.
[Electronic resource]. Hematology Am Soc Hematol Educ Program
2007: 179-86. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18024627 (20.10.2014)
71.
Steele M, Cochrane A, Wakefield C, Stain AM, Ling S, Blanchette V,
et al. Hepatitis A and B immunization for individuals with inherited
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
62
bleeding disorders. [Electronic resource]. Haemophilia 2009; 15:437–
447. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19335752?dopt=Abstract (20.10.2014)
72.
Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal
diagnosis techniques. [Electronic resource]. Fetal Diagn Ther 2010;
27(1):1-7. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20051662 (20.10.2014)
73.
Teitel JM, Barnard D, Israels S, Lillicrap D, Poon MC, Sek J. Home
management of haemophilia. [Electronic resource]. Haemophilia 2004;
10(2):118-33. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/14962201?dopt=Abstract (20.10.2014)
74.
Teitel JM, Carcao M, Lillicrap D, et al. Orthopaedic surgery in
haemophilia patients with inhibitors: a practical guide to haemostatic,
surgical and rehabilitative care. [Electronic resource]. Haemophilia
2009; 15(1):227-39. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18752535?dopt=Abstract (20.10.2014)
75.
Thomas S, Gabriel MB, Assi PE, Barboza M, Perri ML, Land MG, et
al. Radioactive synovectomy with Yttrium90 citrate in haemophilic
synovitis: Brazilian experience. [Electronic resource]. Haemophilia
2011; 17(1):e211-e216. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/20731723?dopt=Abstract (20.10.2014)
76.
Trigg DE, Stergiotou I, Peitsidis P, Kadir RA. A Systematic Review:
The use of desmopressin for treatment and prophylaxis of bleeding
disorders in pregnancy. [Electronic resource]. Haemophilia 2012;
18(1):25-33. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21624012?dopt=Abstract (20.10.2014)
77.
Vinall C, Stassen LF. The dental patient with a congenital bleeding
disorder. [Electronic resource]. J Ir Dent Assoc 2008 Feb-Mar;
54(1):24-8.- Available at:
http://www.ncbi.nlm.nih.gov/pubmed/18405211?dopt=Abstract (20.10.2014)
78.
White GC 2nd, Rosendaal F, Aledort LM, Lusher JM, Rothschild C,
Ingerslev J. Definitions in hemophilia. Recommendation of the
scientific subcommittee on factor VIII and factor IX of the scientific
and standardization committee of the International Society on
Thrombosis and Haemostasis. [Electronic resource]. Thromb Haemost
2001; 85(3):560. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/11307831 (20.10.2014)
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
63
79.
Witmer CM, Manno CS, Butler RB, Raffini LJ. The clinical
management of hemophilia and head trauma: a survey of current
clinical practice among pediatric hematology/oncology physicians.
[Electronic resource]. Pediatr Blood Cancer 2009; 53(3):406-10. -
Available at:
http://www.ncbi.nlm.nih.gov/pubmed/19489052?dopt=Abstract (20.10.2014)
80.
Zanon E, Iorio A, Rocino A, Artoni A, Santoro R, Tagliaferri A, Coppola
A, Castaman G, Mannucci PM; the Italian Association of Hemophilia
Centers. Intracranial haemorrhage in the Italian population of haemophilia
patients with and without inhibitors. [Electronic resource]. Haemophilia
2012 18(1):39-45. - Available at:
http://www.ncbi.nlm.nih.gov/pubmed/21752159?dopt=Abstract (20.10.2014)
81.
Протокол
ведения
больных
«Гемофилия».
Проблемы
стандартизации в здравоохранении. [Электронный ресурс]. 2006,
с. 18 - 74. - Доступно на: http://hemophilia-info.ru/txt/hem.html
(20.10.2014)
82.
Свирин П. В., Вдовин В.В./Федеральные Клинические
рекомендации по диагностике и лечению гемофилии у детей.
[Электронный ресурс]. 2012. - Доступно на:
http://fnkc.ru/documents/10180/20884/Microsoft+Word+pdf/2a195045
-dbd3-40da-96ba-87d1e348c247 (20.10.2014)
Klinik protokol Az
ərbaycan Respublikas
ı S
əhiyy
ə Nazirliyinin
İctimai S
əhi
yy
ə v
ə
İslahatlar M
ərk
əzind
ə haz
ırlanm
ış
dı
r.
Dostları ilə paylaş: |